Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Individual results vary based on baseline metabolic health, lifestyle factors, and protocol adherence
Lab work or additional review may be recommended when clinically indicated
Cat# ab19878
BMJ 2016;352:i581.ArticlePubMedPMC 57
Vascular injury Several immunosuppressive agents such as cyclosporin, tacrolimus, and muromonab-CD3 may cause renal vascular injury by damaging primary endothelium that induces platelet aggregation and consumption
UnitedHealthcare: UHC requires prior authorization for biologics, specialty injectables, and some hormonal therapies administered under this code
US$ 25.93
US$ 27.66
US$ 24.44
